Market Closed - Australian S.E. 10:31:41 2024-06-06 pm EDT 5-day change 1st Jan Change
0.012 AUD 0.00% Intraday chart for dorsaVi Ltd -7.69% 0.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
DorsaVi's AI Natural Movement Algorithm Receives Gold-Standard Validation MT
DorsaVi Launches Video AI for Upper Limb Movement Tracking MT
DorsaVi Adds Real-Time Facial Tracking Feature to Movement Platform; Shares Up 47% MT
DorsaVi Ltd Reports Earnings Results for the Half Year Ended December 31, 2023 CI
DorsaVi Appoints Auditor MT
Australian Shares Rebound Amid 'Encouraging' Progress in Taming Inflation MT
DorsaVi Signs Two US Contracts; Shares Surge 27% MT
DorsaVi Raises AU$500,000 for Product Sales, Enhancements MT
DorsaVi Ltd Appoints Michael Winlo as Non-Executive Director CI
DorsaVi Appoints CFO MT
DorsaVi Ltd Announces Executive Changes, Effective on September 18, 2023 CI
DorsaVi Ltd Announces CFO Changes, Effective on September 18, 2023 CI
DorsaVi Ltd Reports Earnings Results for the Full Year Ended June 30, 2023 CI
DorsaVi to Integrate Video Tracking to Sensor Device; Shares Rally 13% MT
DorsaVi to Enhance Run Module with AI-Based Video Tracking CI
DorsaVi Expands Module Library of Flagship ViMove+ Product MT
Australian Stocks Decline as Energy, Consumer Staples, IT Lead Losses MT
DorsaVi, University of Rochester Medical Center Sign New Contract MT
DorsaVi Raises AU$750,000 for Growth Initiatives MT
DorsaVi Halts Securities Halts Trading Pending Capital Raising Announcement MT
DorsaVi Ltd Reports Earnings Results for the Half Year Ended December 31, 2022 CI
Dorsavi, Medtronic Enter Deal to Develop New Technology; Shares Jump 25% MT
DorsaVi Partners with Medtronic to Develop New Technology CI
DorsaVi Ltd Reports Earnings Results for the Full Year Ended June 30, 2022 CI
DorsaVi Ltd Auditor Raises 'Going Concern' Doubt CI
Chart dorsaVi Ltd
More charts
dorsaVi Ltd is an Australia-based company focused on developing motion analysis device technologies for use in clinical applications, elite sports, and occupational health and safety. Its segments include Clinical and Workplace. The Company's products include Workplace Solutions, ViMove+, ViSafe, and Research+. Workplace Solution enables employers to assess risk of injury for employees as well as test the effectiveness of proposed changes to OHS workplace design, equipment or methods based on objective evidence. Its clinical solutions (ViMove, ViMove2 and Professional Suite) provides objective assessment, monitoring outside the clinic and immediate biofeedback. The clinical market is segmented into physical therapy (physiotherapists), hospital in the home, and elite sports. Hospital in the home refers to the remote management of patients by clinicians outside of physical therapy. Elite sports refer to the management and optimization of athletes through objective evidence.
More about the company
  1. Stock Market
  2. Equities
  3. DVL Stock
  4. News dorsaVi Ltd
  5. DorsaVi Adds Real-Time Facial Tracking Feature to Movement Platform; Shares Up 47%